Generics and Pharmaceuticals

///Generics and Pharmaceuticals

Health system-led drug company unlikely to make a dent in drug prices, shortages

As four not-for-profit health systems unveiled plans to create their own generic drug company Thursday, experts say they'll face an uphill battle to make a significant dent in one of the fastest-growing industry expenses and persistent problems: rising drug prices and drug shortages. Intermountain Healthcare, Ascension, SSM Health and Trinity Health are working with the

2018-02-14T07:33:13+00:00 Tags: |

Kenya becomes first country to debut generic HIV drug

A new generic version of a frontline antiretroviral drug launches in Kenya today, the first time that HIV patients will have access to the more affordable version of the treatment. Dolutegravir, or DTG, will be available to patients through a partnership between the Kenyan Ministry of Health and Geneva-based Unitaid. DTG has been the preferred

2018-02-07T13:26:21+00:00 Tags: |

The power of pharma businesses to drive social change

Poverty, unemployment and inequality are perhaps the biggest challenges facing society today. These issues all urgently need solutions, and businesses bear a responsibility in helping to create them. One of the key ways in which businesses can do this is through Corporate Social Responsibility (CSR) programmes. Investing in CSR programmes can bring business as well

2018-01-31T09:40:26+00:00 Tags: |

Hospitals Launch Their Own Generic Drug Company

A consortium of four healthcare groups, citing frustration with ongoing shortages and high costs of generic medications, announced on Jan. 18, 2018 the formation of a not-for-profit generic drug company. The healthcare groups, Ascension, Intermountain Healthcare, SSM Health, and Trinity Health—working in consultation with the US Department of Veterans Affairs (VA)—represent more than 450 hospitals

2018-01-31T09:44:06+00:00 Tags: |

The story of Alvogen and the founding of a pharma empire

The pharmaceutical sector in the United States is undergoing a seismic shift. In recent years, generic pharmaceuticals, which are equivalent to branded drugs in everything apart from their price and name, have been expanding their share of the market at a rapid pace. At around 50 to 70 percent cheaper than their branded equivalents, more

Leading U.S. Health Systems Announce Plans to Develop a Not-for-Profit Generic Drug Company

To help patients by addressing the often unwarranted shortages and high costs of lifesaving generic medications, Intermountain Healthcare is leading a collaboration with Ascension, SSM Health and Trinity Health, in consultation with the U.S. Department of Veterans Affairs* (VA), to form a new, not-for-profit generic drug company. The five organizations represent more than 450 hospitals

Teva Pharmaceuticals Announces Launch of Generic HIV Drug

The US Department of Health & Human Services reports that 1.1 million individuals in the United States are living with HIV. Furthermore, in 2016, 39,782 individuals were diagnosed with the virus. The good news is, thanks to antiretroviral therapy, a HIV diagnosis no longer equates to a death sentence. Now, Teva Pharmaceuticals Industries Ltd. has announced that

FDA Commissioner on new steps to facilitate efficient generic drug review

The FDA today announced additional steps to encourage generic competition as part of our continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that can delay generic drug entry; resolving scientific and regulatory obstacles that can make it difficult to win approval of generic versions

2018-01-05T10:09:55+00:00 Tags: |

Do generic drugs compromise on quality?

You've no doubt seen them in the grocery store — typically drab-looking packages on the bottom shelf containing lower-priced generic versions of popular brand-name products. Some shoppers look at them with skepticism: Are they really as good? Or does cheaper just mean lower quality? Many people have the same questions about generic prescription medications, says

2018-01-02T08:39:22+00:00 Tags: |

Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels

California's Supreme Court on Thursday ruled against Novartis in a decision that could have wider implications for whether brand-name or generic drugmakers should be held liable for warning consumers of risks in their drug labels. In a departure from other recent rulings, the highest California court found that a brand-name drug manufacturer's duty to warn

2018-01-02T08:32:34+00:00 Tags: |

Decreasing Market Competition Driving Up Generic Drug Costs

As the number of manufacturers producing a generic drug increases, the costs of these drugs fall, a recent study suggests. Chintan V. Dave, PharmD, PhD, from Brigham and Women's Hospital, Boston, Massachusetts, and colleagues reported their findings in a correspondence to the editor published online December 27 in the New England Journal of Medicine. "With

2018-01-02T08:27:19+00:00 Tags: |

Decreasing Market Competition Driving Up Generic Drug Costs

As the number of manufacturers producing a generic drug increases, the costs of these drugs fall, a recent study suggests. Chintan V. Dave, PharmD, PhD, from Brigham and Women's Hospital, Boston, Massachusetts, and colleagues reported their findings in a correspondence to the editor published online December 27 in the New England Journal of Medicine. "With 1.9 billion prescription

Govt needs to strengthen regulatory mechanisms for quality generic drugs

In India, annually an estimated 32 million to 94 million people (Goyanka R, Garg C Charu, Prasad S. - report submitted for publication) get pushed below the poverty line because of expenditure on medical care. About two-thirds of this expenditure is on medicines, making it a major reason for poverty in India (National Health Systems

2017-12-21T11:16:26+00:00 Tags: |

When paying for drugs with insurance costs more than paying cash

It seems logical that customers buying prescription drugs with insurance should pay less than if they pay the entire cost themselves. But sometimes, that is not the case, and patients end up unknowingly paying more if they use insurance. "Pharmacists I talk to are very upset about this, because they see where patients are paying

2017-12-21T11:33:56+00:00 Tags: |

Tackling the High Cost of Prescription Drugs

The high cost of prescription drugs in the United States came under scrutiny in a new report from the National Academies of Sciences, Engineering, and Medicines, “Making Medicines Affordable: A National Imperative,” co-authored by Stanford Law Professor Michelle Mello (former Senator Jeff Bingaman, JD ’68, co-chaired the committee). Published on November 30, the report aims

2017-12-09T07:53:34+00:00 Tags: |

Tackling the High Cost of Prescription Drugs

The high cost of prescription drugs in the United States came under scrutiny in a new report from the National Academies of Sciences, Engineering, and Medicines, “Making Medicines Affordable: A National Imperative,” co-authored by Stanford Law Professor Michelle Mello (former Senator Jeff Bingaman, JD ’68, co-chaired the committee). Published on November 30, the report aims

2017-12-04T13:45:10+00:00 Tags: |

Amazon is in exploratory talks with generic-drug makers

Amazon has held preliminary talks with makers of generic drugs about its potential entry into the pharmacy space, according to people familiar with the discussions. The conversations, including with generics giants Mylan and Sandoz, a unit of Novartis, have been high-level, and the nature of Amazon's plans isn't yet clear, said the people, who asked not to be

Generic drugs: magic cure or sick man of stock markets? 

Generic drug manufacturers are a painful thorn in big pharma’s side. Once a top-selling drug loses its exclusive patent, the launch of rival versions can lead to severe losses in sales and profit for the innovator company. But generic drugs makers could be just what the doctor ordered for investors. After years of research and

U.S. states allege broad generic drug price-fixing collusion

WASHINGTON (Reuters) - A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling. The lawsuit, brought by the attorneys general of 45

2017-11-24T15:03:06+00:00 Tags: |

More generic drugs were approved by the US FDA in FY 2017 than ever before.

By the end of the 2017 fiscal year in September, the US Food and Drug Administration had approved 763 new generic versions of drugs—112 more than it had in 2016, almost twice as many as in 2014. This record push is part of an effort to lower prescription drug costs. Generic drugs, which work the same way